0001894562-24-000018.txt : 20240304
0001894562-24-000018.hdr.sgml : 20240304
20240304212021
ACCESSION NUMBER: 0001894562-24-000018
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240229
FILED AS OF DATE: 20240304
DATE AS OF CHANGE: 20240304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Marrazzo Jeffrey D
CENTRAL INDEX KEY: 0001631262
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-41536
FILM NUMBER: 24717989
MAIL ADDRESS:
STREET 1: 3737 MARKET STREET
STREET 2: SUITE 1300
CITY: PHILADELPHIA
STATE: PA
ZIP: 19104
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prime Medicine, Inc.
CENTRAL INDEX KEY: 0001894562
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 21 ERIE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: 617-465-0013
MAIL ADDRESS:
STREET 1: 21 ERIE ST.
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
wk-form4_1709605211.xml
FORM 4
X0508
4
2024-02-29
0
0001894562
Prime Medicine, Inc.
PRME
0001631262
Marrazzo Jeffrey D
C/O PRIME MEDICINE, INC.
21 ERIE STREET
CAMBRIDGE
MA
02139
1
0
0
0
0
Stock Option (right to buy)
8.63
2024-02-29
4
A
0
250000
0
A
2034-02-28
Common Stock
250000
250000
D
The shares underlying this option shall vest in full on the one-year anniversary of the date of grant, subject to the Reporting Person's continued service through such vesting date.
/s/ Karen Brown, attorney-in-fact
2024-03-04